A. Tejerina

521 total citations
33 papers, 398 citations indexed

About

A. Tejerina is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, A. Tejerina has authored 33 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in A. Tejerina's work include Breast Cancer Treatment Studies (11 papers), Cancer Cells and Metastasis (6 papers) and HER2/EGFR in Cancer Research (5 papers). A. Tejerina is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Cancer Cells and Metastasis (6 papers) and HER2/EGFR in Cancer Research (5 papers). A. Tejerina collaborates with scholars based in Spain, Venezuela and United States. A. Tejerina's co-authors include J. Schneider, Fernando Martínez‐Arribas, Marina Pollán, Miguel Martín, Álvaro Ruibal, Á. Ruibal, Severino González-Roces, Margarita Rubio Alonso, José Ignacio Arias and Apolonia Novillo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and British Journal of Cancer.

In The Last Decade

A. Tejerina

29 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Tejerina Spain 11 245 151 143 72 49 33 398
Ismael D.C.G. Silva Brazil 11 153 0.6× 171 1.1× 118 0.8× 71 1.0× 29 0.6× 17 533
Fukashi Doi Japan 7 154 0.6× 108 0.7× 149 1.0× 36 0.5× 80 1.6× 11 419
Grethe I.G. Alnæs Norway 16 176 0.7× 343 2.3× 197 1.4× 144 2.0× 35 0.7× 19 579
Kazuma Maeno Japan 10 214 0.9× 144 1.0× 55 0.4× 59 0.8× 38 0.8× 32 444
Shigeru Momiki Japan 10 197 0.8× 246 1.6× 128 0.9× 36 0.5× 32 0.7× 28 537
Kevin Dietrich Canada 7 249 1.0× 179 1.2× 56 0.4× 31 0.4× 23 0.5× 14 435
London Lucien Ooi Singapore 12 354 1.4× 231 1.5× 106 0.7× 37 0.5× 33 0.7× 21 719
Xiaopu Yuan United States 9 221 0.9× 111 0.7× 153 1.1× 93 1.3× 49 1.0× 10 384
María José Arcos Spain 10 269 1.1× 152 1.0× 45 0.3× 30 0.4× 89 1.8× 13 868
Aphrodite Nonni Greece 9 118 0.5× 118 0.8× 125 0.9× 33 0.5× 106 2.2× 29 372

Countries citing papers authored by A. Tejerina

Since Specialization
Citations

This map shows the geographic impact of A. Tejerina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Tejerina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Tejerina more than expected).

Fields of papers citing papers by A. Tejerina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Tejerina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Tejerina. The network helps show where A. Tejerina may publish in the future.

Co-authorship network of co-authors of A. Tejerina

This figure shows the co-authorship network connecting the top 25 collaborators of A. Tejerina. A scholar is included among the top collaborators of A. Tejerina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Tejerina. A. Tejerina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosety-Rodríguez, Manuel, Ignacio Rosety, A. J. Díaz, et al.. (2013). Central obesity measurements predict metabolic syndrome in a retrospective cohort study of postmenopausal women. SHILAP Revista de lepidopterología. 1 indexed citations
2.
Fernández‐Santander, Ana, et al.. (2013). Relationship between Genotypes Sult1a2 and Cyp2d6 and Tamoxifen Metabolism in Breast Cancer Patients. PLoS ONE. 8(7). e70183–e70183. 36 indexed citations
3.
López–Pousa, Antonio, et al.. (2010). Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumours. European Journal of Cancer Care. 19(5). 648–655. 29 indexed citations
4.
Schneider, J., et al.. (2008). Molecular subgroups of small (pT1) breast carcinomas belonging exclusively to the ductal infiltrating variety.. PubMed. 4(6). 399–402. 4 indexed citations
5.
Martínez‐Arribas, Fernando, et al.. (2005). The S-phase fraction of the aneuploid cell subpopulation is the biologically relevant one in aneuploid breast cancers. Breast Cancer Research and Treatment. 92(1). 77–80. 4 indexed citations
6.
Martínez‐Arribas, Fernando, et al.. (2003). Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.. PubMed. 23(1B). 565–8. 18 indexed citations
7.
Martínez‐Arribas, Fernando, et al.. (2003). Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype. Breast Cancer Research. 5(3). R65–70. 46 indexed citations
9.
Martínez‐Arribas, Fernando, et al.. (2002). Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.. PubMed. 22(1A). 295–8. 22 indexed citations
10.
Schneider, J., et al.. (2001). Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP.. PubMed. 20(6B). 4373–7. 41 indexed citations
14.
Ruibal, Á., et al.. (2000). Impacto clínico-biológico de la positividad de la pS2 en carcinomas ductales infiltrantes de mama receptor de estrógenos negativos. Revista Española de Medicina Nuclear. 19(6). 428–433. 1 indexed citations
15.
Ruibal, Á., et al.. (2000). Estudio del ácido hialurónico en la membrana celular de procesos mamarios benignos y malignos. Correlaciones clinicobiológicas. 67(6). 551–555. 2 indexed citations
16.
17.
Schneider, John R., et al.. (2000). Cellular accumulation of uPA-PAI-1 [correction of UPA-PAI-1] and uPA-PAI-2 [correction of UPA-PAI-2] complexes in early (pT1) breast cancer: a new link in the uPA-UPAr-PAI chain.. PubMed. 14(4). 507–11. 5 indexed citations
18.
Tejerina, A., et al.. (1999). Biopsia de lesiones radiológicamente sospechosas no palpables de mama mediante el sistema ABBI: experiencia del Centro de Patología de la Mama de Madrid. Revista de Senología y Patología Mamaria. 12(4). 165–169. 1 indexed citations
19.
Schneider, Jens, et al.. (1999). Utilización de factores pronósticos tumorales para predecir la invasión ganglionar de la axila en cáncer de mama precoz.. Revista de Senología y Patología Mamaria. 12(1). 7–11.
20.
Schneider, J., et al.. (1999). Histologic Grade and CD44 Are Independent Predictors of Axillary Lymph Node Invasion in Early (T1) Breast Cancer. Tumor Biology. 20(6). 319–330. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026